Adil E Bharucha
Overview
Explore the profile of Adil E Bharucha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
190
Citations
4960
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Blackett J, Bharucha A
Am J Gastroenterol
. 2025 Mar;
PMID: 40079456
Fecal incontinence (FI) is the involuntary and recurrent loss of stool. FI significantly affects both physical and social well-being, while imposing a substantial economic burden. The global prevalence of FI...
2.
Varma R, Williams C, McClain E, Bailey K, Ordog T, Bharucha A
Neurogastroenterol Motil
. 2025 Jan;
:e15008.
PMID: 39873950
Background: The carbon-13 spirulina gastric emptying breath test (GEBT) is approved to identify delayed, but not accelerated, gastric emptying (GE). We compared the utility of the GEBT to scintigraphy for...
3.
Bharucha A, Bublitz M, Vierkant R, Luehrs T, Konzen K, Weiss D, et al.
Mayo Clin Proc
. 2024 Dec;
100(1):52-67.
PMID: 39641710
Objective: To assess whether the mode and formatting of invitations affect enrollment in a large, decentralized study. Patients And Methods: Between July 1, 2022, and October 30, 2022, we prospectively...
4.
Varma R, Chakraborty S, Ramu S, Burton D, Deb B, Ryks M, et al.
Neurogastroenterol Motil
. 2024 Jul;
36(9):e14857.
PMID: 38946172
Background: This study compared the effects of ondansetron and placebo in patients with diabetes mellitus and symptoms of dyspepsia (diabetic gastroenteropathy [DGE]). Methods: We performed a randomized, double-blinded, placebo-controlled study...
5.
Varma R, Chakraborty S, Burton D, Bailey K, Bharucha A
Neurogastroenterol Motil
. 2024 Apr;
36(7):e14798.
PMID: 38651669
Background: Although diabetic gastroenteropathy (DGE) is associated with small intestinal bacterial overgrowth (SIBO), most studies have evaluated SIBO with a hydrogen breath test, which may be affected by altered transit...
6.
Ramu S, Oblizajek N, Savica R, Chunawala Z, Deb B, Bharucha A
Neurogastroenterol Motil
. 2024 Feb;
36(5):e14767.
PMID: 38376243
Background And Aims: Up to 50% of patients with Parkinson disease have constipation (PD-C), but the prevalence of defecatory disorders caused by rectoanal dyscoordination in PD-C is unknown. We aimed...
7.
Varma R, Staab J, Matey E, Wright J, Deb B, Lazaridis K, et al.
Neurogastroenterol Motil
. 2023 Dec;
36(2):e14722.
PMID: 38072827
Background: How variations predicted by pharmacogenomic testing to alter drug metabolism and therapeutic response affect outcomes for patients with disorders of gut- brain interaction is unclear. Aims: To assess the...
8.
Varma R, Feuerhak K, Mishra R, Chakraborty S, Oblizajek N, Bailey K, et al.
Neurogastroenterol Motil
. 2023 Oct;
36(1):e14697.
PMID: 37890049
Background: Diarrhea and rectal urgency are risk factors for fecal incontinence (FI). The effectiveness of bowel modifiers for improving FI is unclear. Methods: In this double-blind, parallel-group, randomized trial, women...
9.
Mack I, Hahn H, Godel C, Enck P, Bharucha A
Clin Gastroenterol Hepatol
. 2023 Sep;
22(4):712-731.e8.
PMID: 37734583
Background & Aims: Fecal incontinence (FI) can considerably impair quality of life. Through a systematic review and meta-analysis, we sought to determine the global prevalence and geographic distribution of FI...
10.
Gao F, Hayashi Y, Saravanaperumal S, Gajdos G, Syed S, Bhagwate A, et al.
Gastroenterology
. 2023 Aug;
165(6):1458-1474.
PMID: 37597632
Background & Aims: Although depletion of neuronal nitric oxide synthase (NOS1)-expressing neurons contributes to gastroparesis, stimulating nitrergic signaling is not an effective therapy. We investigated whether hypoxia-inducible factor 1α (HIF1A),...